Alpine Immune Sciences, Inc. 34LA.F Stock
Alpine Immune Sciences, Inc. Price Chart
Alpine Immune Sciences, Inc. 34LA.F Financial and Trading Overview
| Alpine Immune Sciences, Inc. stock price | 59 EUR |
| Previous Close | 10.1 EUR |
| Open | 9.85 EUR |
| Bid | 9.85 EUR x N/A |
| Ask | 10.1 EUR x N/A |
| Day's Range | 9.85 - 9.85 EUR |
| 52 Week Range | 5.41 - 10.1 EUR |
| Volume | 305 EUR |
| Avg. Volume | 5 EUR |
| Market Cap | 481.28M EUR |
| Beta (5Y Monthly) | 1.236619 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20 EUR |
34LA.F Valuation Measures
| Enterprise Value | 302.36M EUR |
| Trailing P/E | N/A |
| Forward P/E | -6.4379086 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 18.638365 |
| Price/Book (mrq) | 2.774648 |
| Enterprise Value/Revenue | 11.709 |
| Enterprise Value/EBITDA | -4.603 |
Trading Information
Alpine Immune Sciences, Inc. Stock Price History
| Beta (5Y Monthly) | 1.236619 |
| 52-Week Change | 27.28% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 10.1 EUR |
| 52 Week Low | 5.41 EUR |
| 50-Day Moving Average | 7.54 EUR |
| 200-Day Moving Average | 7.04 EUR |
34LA.F Share Statistics
| Avg. Volume (3 month) | 5 EUR |
| Avg. Daily Volume (10-Days) | 30 EUR |
| Shares Outstanding | 47.97M |
| Float | 26.26M |
| Short Ratio | N/A |
| % Held by Insiders | 6.42% |
| % Held by Institutions | 86.08% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -245.91% |
| Operating Margin (ttm) | -256.68% |
| Gross Margin | -184.69% |
| EBITDA Margin | -254.40% |
Management Effectiveness
| Return on Assets (ttm) | -16.70% |
| Return on Equity (ttm) | -44.56% |
Income Statement
| Revenue (ttm) | 25.82M EUR |
| Revenue Per Share (ttm) | 0.68 EUR |
| Quarterly Revenue Growth (yoy) | -31.10% |
| Gross Profit (ttm) | -40179000 EUR |
| EBITDA | -65693000 EUR |
| Net Income Avi to Common (ttm) | -63501000 EUR |
| Diluted EPS (ttm) | -1.76 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 194.92M EUR |
| Total Cash Per Share (mrq) | 4.06 EUR |
| Total Debt (mrq) | 12.83M EUR |
| Total Debt/Equity (mrq) | 7.57 EUR |
| Current Ratio (mrq) | 3.482 |
| Book Value Per Share (mrq) | 3.55 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -75355000 EUR |
| Levered Free Cash Flow (ttm) | -40055248 EUR |
Profile of Alpine Immune Sciences, Inc.
| Country | Germany |
| State | WA |
| City | Seattle |
| Address | 188 East Blaine Street |
| ZIP | 98102 |
| Phone | 206 788 4545 |
| Website | https://www.alpineimmunesciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 126 |
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for the treatment of B cell-mediated inflammatory and autoimmune diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.
Q&A For Alpine Immune Sciences, Inc. Stock
What is a current 34LA.F stock price?
Alpine Immune Sciences, Inc. 34LA.F stock price today per share is 59 EUR.
How to purchase Alpine Immune Sciences, Inc. stock?
You can buy 34LA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Alpine Immune Sciences, Inc.?
The stock symbol or ticker of Alpine Immune Sciences, Inc. is 34LA.F.
Which industry does the Alpine Immune Sciences, Inc. company belong to?
The Alpine Immune Sciences, Inc. industry is Biotechnology.
How many shares does Alpine Immune Sciences, Inc. have in circulation?
The max supply of Alpine Immune Sciences, Inc. shares is 69.47M.
What is Alpine Immune Sciences, Inc. Price to Earnings Ratio (PE Ratio)?
Alpine Immune Sciences, Inc. PE Ratio is 0.00000000 now.
What was Alpine Immune Sciences, Inc. earnings per share over the trailing 12 months (TTM)?
Alpine Immune Sciences, Inc. EPS is 0 EUR over the trailing 12 months.
Which sector does the Alpine Immune Sciences, Inc. company belong to?
The Alpine Immune Sciences, Inc. sector is Healthcare.